Patient/caregiver was instructed upon therapeutic uses and mechanism of action of Requip as follows: Low levels of the neurotransmitter dopamine and consequent reduced stimulation of dopaminergic receptors in the brain and nervous tissues, result in development of symptoms of Parkinson’s disease. Requip belongs to a class of medications called dopamine agonists, which act in place of dopamine at the dopaminergic receptors. Requip potentiates/increases the stimulation of dopaminergic receptors in the brain and nervous tissues. Potentiation [...]

Patient/caregiver was educated on pathophysiology of Parkinson’s disease as follows: Parkinson’s disease is caused by low levels of a neurotransmitter, dopamine, in the brain. Dopamine is synthesized and secreted by certain nerve cells in the brain. Dopamine helps with transmission of nerve impulse between the brain cells and regulate smooth initiation and execution of movements. Secondary to use of various drugs or infections or chemicals, these dopaminergic neurons in the brain could be damaged. This [...]